Clinical trials
Phase 2/3 Dementia trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
30 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2001 | 1 |
| 2002 | 1 |
| 2004 | 1 |
| 2007 | 2 |
| 2008 | 1 |
| 2009 | 3 |
| 2012 | 2 |
| 2014 | 2 |
| 2015 | 3 |
| 2016 | 1 |
| 2017 | 1 |
| 2018 | 1 |
| 2020 | 3 |
| 2021 | 2 |
| 2023 | 1 |
| 2024 | 4 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 14 |
| Terminated | 6 |
| Recruiting | 4 |
| Active, not recruiting | 3 |
| Unknown status | 3 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Washington University School of Medicine | 6 |
| LeonaBio | 2 |
| VA Office of Research and Development | 2 |
| Actinogen Medical | 1 |
| AstraZeneca | 1 |
| Axovant Sciences Ltd. | 1 |
| Banner Health | 1 |
| Fondation pour l'accueil et l'hébérement des personnes âgées | 1 |
| Janssen Research & Development, LLC | 1 |
| Johns Hopkins University | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Dementia | 30 |
| Alzheimer Disease | 22 |
| Brain Diseases | 3 |
| Lewy Body Disease | 3 |
| Central Nervous System Diseases | 2 |
| Memory Disorders | 2 |
| Mental Disorders | 2 |
| Nervous System Diseases | 2 |
| Agnosia | 1 |
| Cerebral Small Vessel Diseases | 1 |
Trials
Showing 51 to 30 of 30. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.